These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 15497749

  • 1. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
    Hu FQ, Wu MZh, Yuan H, Zhang HH.
    Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
    [Abstract] [Full Text] [Related]

  • 2. Preparation and characterization of solid lipid nanoparticles containing peptide.
    Hu FQ, Hong Y, Yuan H.
    Int J Pharm; 2004 Apr 01; 273(1-2):29-35. PubMed ID: 15010127
    [Abstract] [Full Text] [Related]

  • 3. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization.
    Hu FQ, Yuan H, Zhang HH, Fang M.
    Int J Pharm; 2002 Jun 04; 239(1-2):121-8. PubMed ID: 12052697
    [Abstract] [Full Text] [Related]

  • 4. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
    Yuan H, Huang LF, Du YZ, Ying XY, You J, Hu FQ, Zeng S.
    Colloids Surf B Biointerfaces; 2008 Feb 15; 61(2):132-7. PubMed ID: 17888636
    [Abstract] [Full Text] [Related]

  • 5. Development, characterization and in vitro assessement of stearylamine-based lipid nanoparticles of paclitaxel.
    Pandita D, Ahuja A, Lather V, Dutta T, Velpandian T, Khar RK.
    Pharmazie; 2011 Mar 15; 66(3):171-7. PubMed ID: 21553646
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J, Pang X, Yu K, Liu L, Zhou J.
    Pharmazie; 2008 Aug 15; 63(8):593-7. PubMed ID: 18771008
    [Abstract] [Full Text] [Related]

  • 8. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
    Sandri G, Bonferoni MC, Gökçe EH, Ferrari F, Rossi S, Patrini M, Caramella C.
    J Microencapsul; 2010 Aug 15; 27(8):735-46. PubMed ID: 21034366
    [Abstract] [Full Text] [Related]

  • 9. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
    Kim ST, Jang DJ, Kim JH, Park JY, Lim JS, Lee SY, Lee KM, Lim SJ, Kim CK.
    Pharmazie; 2009 Aug 15; 64(8):510-4. PubMed ID: 19746839
    [Abstract] [Full Text] [Related]

  • 10. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D, Ahuja A, Velpandian T, Lather V, Dutta T, Khar RK.
    Pharmazie; 2009 May 15; 64(5):301-10. PubMed ID: 19530440
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
    Yuan H, Jiang SP, Du YZ, Miao J, Zhang XG, Hu FQ.
    Colloids Surf B Biointerfaces; 2009 May 01; 70(2):248-53. PubMed ID: 19185474
    [Abstract] [Full Text] [Related]

  • 14. Study of solid lipid nanoparticles with respect to particle size distribution and drug loading.
    Patravale VB, Ambarkhane AV.
    Pharmazie; 2003 Jun 01; 58(6):392-5. PubMed ID: 12857001
    [Abstract] [Full Text] [Related]

  • 15. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
    Rahman Z, Zidan AS, Khan MA.
    Eur J Pharm Biopharm; 2010 Sep 01; 76(1):127-37. PubMed ID: 20470882
    [Abstract] [Full Text] [Related]

  • 16. Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).
    Wolska E, Sznitowska M.
    Int J Pharm; 2013 Jan 30; 441(1-2):449-57. PubMed ID: 23164704
    [Abstract] [Full Text] [Related]

  • 17. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY, Du YZ, Chen WW, Yuan H, Hu FQ.
    Pharmazie; 2008 Dec 30; 63(12):878-82. PubMed ID: 19177903
    [Abstract] [Full Text] [Related]

  • 18. beta-Estradiol biodegradable microspheres: effect of formulation parameters on encapsulation efficiency and in vitro release.
    Zaghloul AA.
    Pharmazie; 2006 Sep 30; 61(9):775-9. PubMed ID: 17020154
    [Abstract] [Full Text] [Related]

  • 19. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles.
    Shi K, Cui F, Yamamoto H, Kawashima Y.
    Pharmazie; 2008 Dec 30; 63(12):866-71. PubMed ID: 19177901
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
    Müller RH, Runge SA, Ravelli V, Thünemann AF, Mehnert W, Souto EB.
    Eur J Pharm Biopharm; 2008 Mar 30; 68(3):535-44. PubMed ID: 17804210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.